Skip to main content
logo
Onco-Innovations Limited (NEO:ONCO)
Canada flag Canada · Delayed Price · Currency is CAD
0.7500
+0.1000 (15.38%)
Jul 30, 2026, 12:56 PM EST

Onco-Innovations Financials Overview

Millions CAD. Fiscal year is May - Apr.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23
Revenue
0.110.110.07--
Revenue Growth
30.18%69.06%---
Gross Profit
0.110.110.07--
Operating Income
-10.78-10.78-4.67-0.06-0
Net Income
-10.78-10.78-7.56-0.06-0
Earnings Per Share
-0.19-0.19-0.18-0.04-234.00
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23
Net Cash (Debt)
0.780.781.11-00.02
Net Cash Growth
--30.21%---
Cash & Investments
0.780.781.1100.02
Net Cash Per Share
0.010.010.03-18517.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23
Operating Cash Flow
-5.27-5.27-3.87-0.01-0
Free Cash Flow
-5.27-5.27-3.87-0.01-0
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23
Gross Margin
100.00%100.00%100.00%--
Operating Margin
-9763.39%-9763.39%-7151.57%--
Pretax Margin
-9763.39%-9763.39%-11580.58%--
Profit Margin
-9763.39%-9763.39%-11580.60%--
FCF Margin
-4772.97%-4772.97%-5925.34%--

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2024FY 2023
Period EndingJul '26 Apr '26 Apr '25 Apr '24 Jan '24 Apr '23
PS Ratio
351.80653.29874.80---